IP Library Granted Patent US 11,786,292
Granted Patent B2
US 11,786,292 · App. 17/575,889 · Granted Oct 17, 2023

Integrated nasal nerve detector ablation-apparatus, nasal nerve locator, and methods of use

Inventors: William Jason Fox (San Mateo, CA); David Moosavi (Redwood City, CA); Mojgan Saadat (Atherton, CA); Vahid Saadat (Atherton, CA); Caroline Sobek (Redwood City, CA); Neekon Saadat (Redwood City, CA)
Assignee: Arrinex, Inc.
A61B18/1442A61B5/01A61B5/0538A61B5/065A61B5/4836A61B5/4893A61B5/6819A61B5/6877A61B18/02A61B18/1492A61B17/24A61B18/1485A61B34/20A61B2018/0022A61B2018/00327A61B2018/00434A61B2018/00577A61B2018/00696A61B2018/00791A61B2018/00875A61B2018/00904A61B2018/00982A61B2018/0212A61B2018/1495A61B2562/0209A61N1/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,786,292
App. No.
17/575,889
Granted
Oct 17, 2023
Kind
B2
Abstract

Systems and related methods for identifying and/or ablating targeted nerves are provided. A probe with stimulating electrodes and/or ablation members are provided. The probe may be inserted into a nasal cavity and current may be introduced through the electrodes to stimulate a targeted area. The response to stimulation may be used to identify the targeted nerve. Once identified, the ablation member may ablate the targeted nerve.

Claims (29)

1. A system for ablating at least one nasal nerve associated with at least one symptom of rhinitis, the system comprising:

a probe shaft having a proximal end and a distal end;

an expandable ablation member permanently coupled to the distal end of the probe shaft;

at least two electrodes disposed on a distal tip that is releasably coupled to the probe shaft, the at least two electrodes electrically coupled to an electrical source, wherein the at least two electrodes are configured to electrically stimulate at least one nasal nerve underlying a nasal surface in contact with the least two electrodes in response to an electrical current generated by the electrical source, wherein the least two electrodes are configured to detect a parameter indicative of a physiologic response to the electrical current; and

a processor operatively coupled to the electrical source, wherein the processor is configured to:

control the electrical current generated by the electrical source,

receive the parameter indicative of the physiologic response to the electrical current, wherein the physiologic response is at least one physiologic response selected from a group consisting of: a change in nasal secretion and a change in arterial blood flow, and

control, based on the parameter, the electrical current generated by the electrical source to cause the least two electrodes to ablate the at least one nasal nerve underlying the nasal surface to reduce the at least one symptom associated with rhinitis.

2. The system of claim 1 , wherein the at least two electrodes are spaced apart in a range from 1 mm to 10 mm.

3. The system of claim 1 , wherein the at least two electrodes are configured to stimulate 1 mm to 3 mm under the nasal surface in contact with the at least two electrodes.

4. The system of claim 1 , wherein the probe shaft is sized so that the distal end of the probe shaft can reach a nasal mucosa covering a medial pterygoid plate of sphenoid bone through a passage of a middle nasal meatus from outside a nasal cavity.

5. The system of claim 1 , wherein the processor is configured to control at least one feature selected from a group consisting of: a voltage, a frequency, and a pulse rate of the electrical current.

6. The system of claim 1 , wherein the parameter is at least one parameter selected from a group consisting of: an electrical resistance, a temperature, and a degree of tumescence of the at least one nasal nerve underlying the nasal surface.

7. The system of claim 6 , wherein the at least two electrodes are configured to detect a change in electrical resistance in an electrical signal passing through the at least two electrodes after stimulation of the at least one nasal nerve underlying the nasal surface, the change in resistance being indicative of a change in nasal secretion after stimulation of the at least one nasal nerve underlying the nasal surface.

8. The system of claim 1 , wherein the expandable ablation member comprises an electrically non-conductive surface, and wherein the at least two electrodes are disposed on the electrically non-conductive surface of the expandable ablation member.

9. The system of claim 1 , wherein a first electrode of the at least two electrodes is disposed at a central location of the expandable ablation member, and a second electrode of the at least two electrodes is disposed along a perimeter of the expandable ablation member.

10. The system of claim 1 , wherein the at least two electrodes comprises four electrodes arranged rectangularly on the expandable ablation member such that the four electrodes are configured to stimulate four quadrants of the expandable ablation member.

11. The system of claim 1 , wherein the expandable ablation member is configured to inflate so as to position the at least two electrodes adjacent to the nasal surface.

12. The system of claim 1 , wherein the expandable ablation member comprises an expandable cryoablation member configured to cryogenically ablate the at least one nasal nerve to reduce at least one symptom associated with rhinitis.

13. The system of claim 1 , wherein the distal tip includes a connector that is coupled to a connection portion of the probe shaft that is proximal to the expandable ablation member.

14. The system of claim 13 , wherein the distal tip extends from the connection portion to a distal end disposed distally of the expandable ablation member, and wherein the at least two electrodes are disposed at the distal end of the distal tip such that the at least two electrodes are distal to the expandable ablation member.

15. The system of claim 1 , wherein the processor is further configured to:

control the electrical current generated by the electrical source through the at least two electrodes after ablating the at least one nasal nerve to confirm that the at least one nasal nerve has been ablated.

16. The system of claim 1 , further comprising:

at least one sensor, wherein the sensor is configured to detect the parameter indicative of a physiologic response to the electrical current, and wherein the at least one sensor is disposed on the probe shaft.

17. The system of claim 1 , wherein controlling the electrical current generated by the electrical source comprises delivering electric pulses through the at least two electrodes at a frequency between 0.5 impulses per second to 12 impulses per second.

18. The system of claim 1 , wherein the processor is further configured to:

measure a response to the electrical current using the at least two electrodes; and

provide an indication to reposition the probe and stimulating the at least two electrodes until a desired response is measured using the at least two electrodes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2022
From: FOX, WILLIAM JASON; MOOSAVI, DAVID; SAADAT, MOJGAN; SAADAT, VAHID; SOBEK, CAROLINE; SAADAT, NEEKON
To: ARRINEX, INC.
Reel/Frame 058657/0899 →
Continuity (3)
Continuation 15786306 · Oct 17, 2017
Provisional Application 62408920 · Oct 17, 2016
Related Publication 20220133395A1 · May 5, 2022
Cited By (2)
US 12,232,799 US 12,357,817